CAS: 2247919-28-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AAPK-25 REF: 3D-XPD91928CAS: 2247919-28-2 | Min. 95% | To inquire | Tue 18 Feb 25 |
 | AAPK-25 REF: TM-T10215CAS: 2247919-28-2 | 97.79% | 95.00 €~2,339.00 € | Tue 11 Mar 25 |
AAPK-25
CAS:2247919-28-2
AAPK-25 is a synthetic, small molecule that inhibits the activity of a protein called Bromodomain …
Formula:
C30H35ClN4O2
Purity:
Min. 95%
Molecular weight:
519.1 g/mol
Ref: 3D-XPD91928
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
AAPK-25
CAS:2247919-28-2
AAPK-25, a dual Aurora/PLK inhibitor, disrupts mitosis, induces apoptosis, and has antitumor properties.
Formula:
C21H13Cl2N3O2S
Purity:
97.79%
Color and Shape:
Solid
Molecular weight:
442.32
- Inhibitors
- Apoptosis
- Cell Cycle/Checkpoint
- Chromatin/Epigenetics
- See more categories
- Aurora Kinase
Ref: TM-T10215
| 1mg | 95.00 € | ||
| 5mg | 199.00 € | ||
| 10mg | 299.00 € | ||
| 25mg | 543.00 € | ||
| 50mg | 814.00 € | ||
| 100mg | 1,182.00 € | ||
| 1mL*10mM (DMSO) | 230.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
